Oct. 21, 2025 — GT Medical Technologies has announced the interim results from its ROADS clinical trial (Randomized Controlled Trial of Resection [Surgery] and GammaTile versus Standard of Care) in patients with operable, newly diagnosed brain metastases.1
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now